Add to basket

Our city and region is ready for you and your business. Explore this snapshot to find out why.


Connected city

x

Connected city

We have regional, national, European and global connections. To keep us ahead £1.3 billion will be invested in our networks by 2015.

Easy access to 400 million people across Europe

90% of UK consumers are within four hours travel time

High Speed 2 rail  – London in less than 45 minutes 

50 airlines serving more than 140 routes worldwide


Multi-sector strengths

x

Multi-sector strengths

Our talented people use their skills and expertise across a range of key sectors.

60% of the UK’s automotive R&D from the region

More BPFS companies than Zurich, Manchester and Edinburgh

23,700 people in architecture and engineering

500 medical technology companies, more than any other UK region


Space to breathe

x

Space to breathe

Birmingham was voted best UK city outside of London for quality of life (Mercer Quality of Living 2012).


With more than 600 parks and open spaces and Sutton Park as one of the largest urban parks in Europe there is always space to breathe

Slow down. Explore more miles of canal than Venice

Secure future - 10 Local Nature Reserves and 156 designated nature conservation sites


World class city of culture

x

World class city of culture

Indoors, outdoors, participate, watch or find space and quiet to get away from it all. You will always be able to relax and unwind.

Birmingham was ranked among the New York Times’ top 20 international destinations to visit.

Explore cuisine from more than 27 countries and dine in more Michelin star restaurants than any other English city outside London

More than 500,000 works of art in one square mile


High quality workforce

x

High quality workforce

Our large talent pool is highly ranked now. It will stay that way.

4.3 million people of working age within an hour of the city

Over 300,000 students and 100,000 graduates within an hour’s drive of the city

A digital hub - for example 21% of the UK's games industry workforce is here

Nearly 1 million people speak a second language


Growth engine

x

Growth engine

Our £94 billion regional economy will grow 20% by 2020

Innovative economic zones generating £1.5bn and 50,000 new jobs

Home to 75,000 companies, 1,190 of which are international

Our population will grow to 1.17million by 2018 (ONS)

Birmingham New Street helps move nearly 25million passengers annually

Europe's youngest city, with under 25's nearly 40% of our population


Bold regeneration

x

Bold regeneration

We are investing £18 billion by 2026 in a bold 21st Century regeneration plan.

£1.3 billion will be invested in road, rail and air networks by 2015

£25 million is going in to the Digital Media Academy and £188 million on the new Library of Birmingham

£600 million redevelopment of New Street Station is underway

Life Sciences

The Greater Birmingham region is located in the very centre of the UK, anchored by Birmingham; a dynamic and ambitious city, the biomedical and medtech community is the rising star in worldwide life science destinations. Perfect for expanding companies in the Life Sciences industry, the region combines extensive research and development facilities, strong collaboration between academia and business as well as one of Europe’s largest, most diverse and non-transient patient populations.

With state-of-the-art clinical facilities, population scale and diversity and pioneering partnerships between academics and clinicians, Greater Birmingham is truly at the cutting edge of medical technology and global healthcare.

The region is going through an unprecedented period of transformation, and is leading post recession national growth and development trends. With record levels of infrastructure investment, increasing international recognition and countless opportunities for companies to thrive in the region, there has never been a better time to invest in Greater Birmingham.

Business Birmingham and Solihull for Success are inward investment agencies working together to attract foreign direct investment and promote development in the area as part of the European Regional Development Fund (ERDF) Investing in Greater Birmingham programme, on behalf of the Greater Birmingham and Solihull Local Enterprise Partnership (GBSLEP).

Life Sciences in the UK

  • The strongest bioscience cluster in Europe (Bio-Industry Association).
  • The UK is home to four of the world’s top 10 universities for clinical, pre-clinical and health subjects.
  • One sixth of the most popular prescription medicines were developed in the UK.
  • 17 of the 20 biggest pharmaceutical companies in the world have research and development, manufacturing and sales sites across the UK.

Life Sciences in Greater Birmingham

  • The large, ethnically diverse, non-transient, regional population of nearly six million offers the perfect landscape for delivering clinical trials.
  • The Institute of Translational Medicine is a world-class clinical research facility in Greater Birmingham. It serves as an engine to translate laboratory discovery into improved and increasingly personalised patient care, with bioinformatics and precision medicine at its core.
  • Internationally recognised clinical academic community.
  • One of largest clinical trials’ portfolios in Europe, immediate access to both state-of-the-art facilities for experimental medicine and world-leading academic expertise.
  • Ready access to Life Sciences infrastructure through Queen Elizabeth Hospital Birmingham (QEHB), one of the largest teaching hospitals in Europe.
  • 600 medical technology companies, more than any other UK region.
  • Globally, one of the few centres equipped to deliver the full circle of translational medicine The University of Birmingham has the second largest medical school in the country. Universities across the region provide significant numbers of high calibre graduates in medical, biochemistry, engineering and related fields to meet the future needs of investors.
  • A high quality IT infrastructure is in place to support Life Sciences activity: the QEHB has a world-class track record in the design, delivery and commercialisation of clinical decision support systems.
  • Birmingham Health Partners, a pioneering alliance between academics and clinicians, that aims to translate laboratory discoveries into clinical practice at a pace, scale and efficiency which is unrivalled in the UK.
  • BHP provides a framework for unique output and interaction with SMEs in addition to global pharmaceutical and diagnostics companies.
  • Home of the largest NIHR Wellcome Trust Clinical Research Facility in the UK (a facility that provides high-quality clinical environments where patients can take part in experimental and complex clinical research studies), a national Biomedical Research Unit in Liver Disease, a centre for Rare Diseases, the largest specialist Cancer Trials Unit in the UK and a national centre for Trauma Research.
  • A new £353 million Midland Metropolitan Hospital in Greater Birmingham will deliver a medical and economic boost to the region. Construction work has begun and it is due to open in October 2018, serving an area of over half a million people.

Case Studies

There is a wealth of opportunity for SMEs to grow and diversify, and to reflect the multiplicity of existing life science businesses in Greater Birmingham we have listed a selection here.

Binding Site
The Binding Site Group Ltd dates back to the early 1970s when a group of researchers within the Medical School of Birmingham University first started looking at innovative ways of producing antibodies. They founded a private company which has evolved into Binding Site and is now one of the largest independent providers of specialist in vitro diagnostic tests and equipment in the UK and the World leader in special protein testing.

Today it employs more than 700 people across all major markets worldwide, with offices in the UK, USA, Belgium, Czech Republic, France, Germany, Italy and Spain.

Binding Site exports ~90% of the products manufactured at its Birmingham head office and international trade has more than doubled between 2010 and 2015, with total worldwide Group revenues last year exceeding £80million. Most recently, Binding Site were recognised for their exceptional achievement in International Trade with a 2016 Queen’s Award for Enterprise.

In 2011, Binding Site relocated to new headquarters in Birmingham city centre, having had its roots at the University.

The company has opted to stay in the region not just because of its strong links with the University of Birmingham, but access to a multi-cultural population mix as well as excellent transport links.

www.bindingsite.com

Safe patient Systems
Safe Patient Systems solves clinical problems by creating simple and patient centric mobile solutions, designed by clinicians that harness technology to enable more efficient healthcare and improved patient outcomes. Born out of the Research and Development department of one of the UK’s leading NHS Trusts, Heart of England NHS Foundation Trust, the company shares many of the values of the NHS around how it prioritises patients, listens, learns and develops evidence-based solutions.

When moving from its existing base at Heartlands hospital, Solihull was a first choice largely due to the prestigious location and great transport links. The motorway provides easy access to the South East where a large number of technology partners are based.
www.safepatientsystems.com

Abingdon Health
Abingdon Health is a UK based medical diagnostics group focused on developing, manufacturing and commercialising point of care immunoassay tests for disorders of the immune system. Their initial focus is on developing rapid tests for haematology oncology and specifically B cell dyscrasias.

They launched the world’s first rapid diagnostic device in multiple myeloma in March 2015, Seralite®– FLC. The contract services team provides assay development and manufacturing services for customers looking to transfer existing laboratory based assays to a lateral flow format. They take projects from initial concept through to transfer to production. Abingdon Health are located in The BioHub Birmingham®.
www.abingdonhealth.com

Celentyx
Celentyx was founded upon applied research originating from the world-renowned Medical Research Council (UK) Centre for Immune Regulation, situated in the University of Birmingham Medical School.

The founders, Professor Nicholas Barnes and Professor John Gordon were amongst the first to recognise that many neurotransmitters also modify the immune system and are internationally recognised authorities in this relatively new field of neuroimmunopharmacology. Their development of ImmuKnowlogy™ provides an efficient toolbox of routine and sophisticated methodologies to aid pharma R&D by understanding the effect of small molecule and biological candidate therapeutics upon the human immune system in health and disease.

www.celentyx.com

Unrivalled Proximity

The core of our life science region is situated a few minutes south of the city centre, by train, car or bus, and contains the majority of our centres of excellence and key life science assets. You can walk between all locations in 15 minutes!

In the wider region you can access academics, business and clinicians within an hour by train or car.

The proximity of all our key strengths enables collaboration and accelerates growth.

Life Sciences Campus
Close to the University of Birmingham and the Queen Elizabeth Hospital Birmingham, development is underway for a cutting edge Life Sciences Campus. This will create up to 50,000sqm of new floor space across a number of 3-4 storey buildings in a campus setting, providing a high quality environment for new and growing businesses.

The space will be suitable for research and development, clinical trials, pharmaceutical manufacturing and regional headquarters; an ideal expansion destination for SMEs from around the world.

The Life Sciences Campus is located within an internationally- recognised clinical academic community whose competitive advantages are unrivalled in the UK with the successful commercialisation of healthcare innovation.

This includes the new Institute of Translational Medicine, a world class clinical research facility, which will play a pivotal role in supporting the expansion of life sciences research and education in Birmingham and the region.

It will facilitate SMEs and large pharma and biotechnology firms to work more closely with clinicians and academics, and create an effective entry for industry partners e.g. Pharma, Diagnostics, Medical Devices and Digital Health into the complex world of healthcare research and routes to market.

The wider Edgbaston area already provides a world class centre of scientific excellence with a proliferation of hospitals, medical organisations, specialist care centres, GP clinics and routine care facilities as well as training facilities.

Working with membership organisations such as MediLink West Midlands, and WMAHSN, region wide industry and collaboration specialists, companies have access to comprehensive industry knowledge and meetings with industry experts, who will help develop businesses and maximise the commercial opportunities within the network.

Insititute of Translational Medicine
Located at the heart of Greater Birmingham’s Life Sciences campus, the Institute of Translational Medicine (ITM) is a world class facility that capitalises on Birmingham being one of the few centres internationally that can provide a bespoke multidisciplinary translational environment for development and delivery of stratified medicine, clinical trials, rare diseases, biomarkers and device evaluation.

As a central meeting point and working hub, it will allow clinicians, academics, bioinformaticians, patient groups and industry leaders to maximise interaction and develop productive collaborative networks.

It will facilitate the swift assessment of cost-effective new drugs and medical devices to bring them to market faster and to frontline use within clinical settings. The ITM is expected to support the creation of 600 new jobs within the research community in its first five years.

The ITM is being delivered by Birmingham Health Partners, a collaboration that brings together the clinical, scientific and academic excellence of University Hospitals Birmingham NHS Foundation Trust (UHB), the University of Birmingham (UoB) and Birmingham Children’s Hospital NHS Foundation Trust (BCH), and Birmingham Women’s Hospital (BWH).

Calthorpe Estate & Edgbaston Medical Quarter
Calthorpe Estates is one of the UK’s most forward-thinking and progressive property investment and development companies. Family-owned since 1717, the prime focus of the business is the prestigious Calthorpe Estate which offers medical and clinical accommodation ranging from new build clinics through to medical suites and individual consulting rooms.

Home to over 550 medical companies, more than any other region in the country, Edgbaston Medical Quarter is fast developing an international reputation for medical excellence. Many are at the cutting edge of world-class medical technology and provide a base for leading students and practitioners from the UK’s most important medical facilities.

As a dedicated centre for healthcare and life sciences, the estate covers 610 hectares in Edgbaston, with its Pebble Mill site located only 1 mile from the University of Birmingham, Queen Elizabeth Hospital Birmingham and the new Life Science Campus in Selly Oak.

Close to Birmingham’s city centre, this thriving commercial and residential district also incorporates one of the UK’s largest urban conservation areas. Edgbaston is an ideal location for SME companies who need to access a clinical base for product development, clinical trials or procurement routes.

Home to 64% of the city’s healthcare economy, the Edgbaston Medical Quarter boasts 180 medical organisations, 23 training facilities allied to medicine, 44 GP clinics and routine care facilities and 80 hospitals and specialist care centres.

Birmingham Research Park
Birmingham Research Park is a thriving community of medical and biomedical activity. Based at the University of Birmingham, the park’s flagship offering is The BioHub Birmingham®; a fully serviced biomedical laboratory and vibrant innovation office designed to provide entrepreneurs and start-ups with access to affordable facilities and equipment. The new facility has been enabled by a £7 million investment by the ERDF, University of Birmingham and Birmingham City Council.

Pebble Mill
At the heart of the burgeoning healthcare cluster, the 27 acre site currently comprises the Birmingham Dental Hospital and School of Dentistry, a BUPA Care Home, and a new Circle Health Private Hospital, bringing industry and academia together into a hub of collaboration and best practice across clinical and medical platforms.

The  New Birmingham Dental Hospital and School
This £50 million project is the first integrated dental hospital and school built in the UK for almost 40 years and offers 154 dental chairs. It is equipped to treat over 120,000 patients a year and provides world class learning and research facilities for more than 600 students. It offers a wide range of clinical services including emergency dental care, restorative dentistry, oral surgery and medicine, orthodontics and paediatric dentistry.

Midlands Metropolitan Hospital
The planned central super hospital involves £300 million worth of public and private investment generating greater opportunities surrounding medical technology, staffing, sub-contracting and research. The hospital site will span 16 acres, and provide 670 beds and will expand on the services currently offered by Sandwell and West Birmingham Hospitals NHS Trust, whilst the concentration of acute specialist care will attract and retain highly skilled clinicians to the region. The hospital is on schedule for opening late 2018 and is a testament to the quality of the scientific and medical environment in Greater Birmingham.

WMAHSN and MediLink WM
The West Midlands Academic Health Science Network (WMAHSN) leads, catalyses and drives co-operation, collaboration and productivity between academia, industry, health and care providers and commissioners, and citizens, and accelerates the adoption of innovation to generate continuous improvement in the region’s health and wealth.

On behalf the West Midlands’ population, WMAHSN’s mission is to deliver improved healthcare outcomes and create economic growth by the spread of proven innovations at scale and pace regionally, nationally and internationally.

MediLink WM, a membership organisation with a remit to stimulate growth and innovation in the medical and health technology sector, operates as the Industry Gateway for WMAHSN.

The WMAHSN is one of 15 AHSNs across England, and is located within the Institute of Translational Medicine.

Opportunity

Birmingham Health Partners

Birmingham Health Partners is a strategic alliance between University Hospitals Birmingham NHS Foundation Trust, University of Birmingham, Birmingham Children’s Hospital NHS Foundation Trust and Birmingham Women’s Hospital, bringing together clinical, scientific and academic excellence across an integrated medical and Life Sciences campus.

The long term objectives of BHP are to improve healthcare; contribute to the local economy through job creation and inward investment into the biomedical sector, and increase public engagement and education about biomedicine and clinical research through increased enrolment into early and late phase clinical trials.

Its short term strategic objectives focus on the identification, adoption and spread of innovation and best practice, through the alignment of healthcare delivery, research and training.

Skills, Training and Recruitment

Our academic centres produce several thousand life science graduates each year, in numerous disciplines such as biomedical sciences, medicine, neuroscience, dental science and healthcare management.

There are several regional initiatives to continue the flow of students into our STEM (Science, Technology, Engineering, Mathematics) talent pool:

  • The University of Birmingham has established a STEM Education Centre, as a direct legacy of the National HE STEM Programme. The Centre is delivering a range of STEM enhancement and enrichment activities across the University.
  • Located at Birmingham City University’s Centre for Enterprise Systems, the Academy Cube’s UK National Office aims to develop the strategic alignment with the STEM agenda in the UK and Ireland to build the next generation of talent for industry, addressing the challenges of employability, skilling and apprenticeship opportunities.
  • Government funding has created the STEAMHouse project at Birmingham City University, driving the creation of up to 10,000 jobs and is a project between businesses, academics, artists (Art) and local communities.

Birmingham City Council and Business Birmingham also provide bespoke training and recruitment services to meet the business needs of investors.

Funding 

There may be potential discretionary funding support available through Birmingham City Council, the Midlands Engine and Finance Birmingham, depending on the nature of the investment project. The Local Enterprise Partnerships (LEPs) also offer financial support to SMEs through the Business Growth Programme.

There are also significant private investment funds and advisors based in the region, which Business Birmingham can facilitate introductions to.

For more information on how we can help contact us on 0121 202 5022 or email [email protected]

Business Birmingham

Business Birmingham is the city's award winning inward investment agency for the UK’s second city, the link to establishing or growing a company’s presence in Greater Birmingham. We are the access point to Greater Birmingham’s business networks and to the numerous benefits from the region’s strong enterprise culture.

We work with investing companies by creating strategic, relevant partnerships, which in turn generate long-lasting business solutions.
By taking this consultative approach with local, national and global businesses, we can provide relevant information and a comprehensive package of support services. Through us, companies have direct access to a unique network of skills, knowledge and assistance.

In 2015/16, the West Midlands achieved the highest regional foreign direct investment in the UK, an attainment which illustrates how our approach is contributing to the region’s continued growth.

Solihull For Success

Supported by a highly-qualified skills base and strong track record in high-value business activities, Solihull continues to draw interest from global corporations and small entrepreneurial businesses alike, paving the way for innovation and growth.

UK Central (UKC) is a unique concentration of strategic economic assets and infrastructure at the heart of the UK’s transport network. Comprising of Birmingham Airport, the NEC and the planned HS2 development, UKC is already a key driver of the regional economy, attracting investment and creating jobs.

UK Central is located in the centre of the UK, less than an hour from London and with direct air links to major European capitals, the United States, Asia and the Middle East.

Academic & Research Centres of Excellence

The region’s strong clinical and life sciences academic centres of excellence enable today’s global healthcare challenges to be explored and addressed by experts from healthcare, academia and industry.

The University of Birmingham

The University consists of five Colleges, four of which provide major contributions to Life Sciences research and education in Birmingham. These are the Colleges of Medical and Dental Sciences, Life and Environmental Sciences, Social Sciences and Engineering and Physical Sciences.

Together they push back the boundaries of translational research with the aim of finding solutions to big issues affecting society. There are five principal thematic Life Science research areas which bring together researchers from across the University and the wider Birmingham Life Science campus: Cancer and Genomic Sciences; Environment, Health and Wellbeing; Immunity and Infection, Inflammation and Chronic Diseases; and Bioengineering, Regeneration and Rehabilitation."

The University works closely with NHS partners including Birmingham Health Partners (BHP), an exciting collaborative platform between the University, Birmingham Hospitals Birmingham NHS Foundation Trust, Birmingham Children's Hospital, and Birmingham Women's Hospital - to deliver world leading research activities in basic and clinical science.

Aston University

With its focus on the application of knowledge for economic & social benefit, Aston University has a distinct mission that sets it apart; to be the UK’s leading University for business, enterprise and the professions, where original research has a positive impact on the world.

The School of Life & Health Sciences pursues interdisciplinary research extending from the laboratory to the clinic. Work ranges from molecular and cellular, through neural systems and human behaviour, to the restoration of health and the study of individuals in health care and societal settings.

Aston University’s initiative for a Medical School in the heart of Birmingham has recently been endorsed by Leicester Medical School. Aston Medical School is planned to open to 60 undergraduate medical students growing to around 100 new medical students each year. It includes a research institute focused on cardiovascular diseases, maternity and child health allowing Aston Medical Research Institute to address the challenge of high perinatal mortality and also pre-eclampsia.

The new Medical School will build upon Aston University’s pioneering health research, including optometry, age-related illnesses such as dementia and chronic diseases including diabetes. The University is also home to the Aston Brain Centre, which specialises in epilepsy, dyslexia, autism, ADHD and sleeping disorders. It provides a referral service for the National Health Service and houses a brain scanner specifically for children – one of only three in the world.

Birmingham City University

Birmingham City University is the second largest of five universities in the city and with more than 7,000 students, is one of the largest providers of nursing and healthcare education. The university has recently invested £41 million in new facilities that promise a major contribution to the health and wellbeing of Greater Birmingham.

The expansion of the University’s campus in Edgbaston will feature specialist laboratories for a newly created School of Life Sciences, offering a range of courses in health, nutrition and biomedicine. The 10,000m² building will reinforce Birmingham City University's status as the region’s largest provider of qualified health and social care professionals.

Institute of Digital Health

The Institute of Digital Healthcare (IDH) is hosted by, Warwick Manufacturing Group (WMG), in partnership with the Warwick Medical School (WMS), and supported by the NHS. IDH aims to improve people's health and wellbeing through the development, evaluation and use of innovative digital technologies and services.

The IDH model of research-led innovation in healthcare entails identifying real problems, understanding them by identifying relevant theories, selecting appropriate technologies and developing new solutions where necessary. Each solution then needs rigorous evaluation for safety, effectiveness and cost implications before promotion to healthcare systems.

The IDH works closely with industry, the NHS and across many disciplinary boundaries. It employs experts in biomedical and information engineering, health psychologists, statisticians and clinicians with public health, hospital medicine and community health backgrounds.

Universities Centre 

The Universities Centre, due to open in 2016, is designed to make it easier for SMEs to engage with Birmingham's five universities, and will help to accelerate digital health innovation. It is co-located with Aston University and iCentrum, an incubator for digital and creative start-ups.

Unrivalled Clinical Research

Greater Birmingham has strong Life Sciences research capabilities, where NHS and private research facilities are supported by an outstanding academic research base at local universities. Global leaders GlaxoSmithKline, Eli Lilly, Pfizer, UCB Celltech, AstraZeneca, Celgene and Novartis have all supported Life Sciences research at the University of Birmingham, while Aston University’s collaborators include The Wellcome Trust and Spectrum Théa.

University Hospitals Birmingham NHS Foundation Trust is one of the leading hospital trusts in Europe. The city’s state-of-the-art hospital facilities include the £545 million Queen Elizabeth Hospital Birmingham (QEHB), home to the largest solid organ transplantation programme in Europe, the largest renal transplant programme in the UK, the Royal Centre for Defence Medicine (RCDM) and has the world’s largest single-floor critical care unit.

Accelerated Trials

Birmingham’s unique infrastructure offers an integrated research and innovation platform that spans discovery, development, validation, clinical implementation, and ultimately evaluation, completing the full circle of translational medicine. The ITM will play a key role in facilitating this, making it the go-to location for accelerated execution and adoption of clinical trials in a real life setting.

The University of Birmingham and University Hospitals Birmingham NHS Foundation Trust (part of the Birmingham Health Partners strategic alliance) currently hosting one of the largest specialist Cancer Trials Unit in the UK, and are internationally recognised for delivering clinical programmes for liver, renal and stem cell transplantation over the last two decades.

Investment in a £24 million Institute of Translational Medicine now provides a centre of excellence across a range of major health issues including cancer and liver disease, complementing the Centre for Clinical Haematology at the QEHB, which hosts an internationally competitive early phase clinical trials portfolio.

Royal Centre for Defence Medicine

Birmingham’s unique infrastructure offers an integrated research and innovation platform that spans discovery, development, validation, clinical implementation, and ultimately evaluation, completing the full circle of translational medicine. The ITM will play a key role in facilitating this, making it the go-to location for accelerated execution and adoption of clinical trials in a real life setting.

The University of Birmingham and University Hospitals Birmingham NHS Foundation Trust (part of the Birmingham Health Partners strategic alliance) currently hosting one of the largest specialist Cancer Trials Unit in the UK, and are internationally recognised for delivering clinical programmes for liver, renal and stem cell transplantation over the last two decades.

Investment in a £24 million Institute of Translational Medicine now provides a centre of excellence across a range of major health issues including cancer and liver disease, complementing the Centre for Clinical Haematology at the QEHB, which hosts an internationally competitive early phase clinical trials portfolio.

Population

Greater Birmingham has one of the most diverse populations in the UK and combined with its diversity in socio-economics, the region provides an unrivalled patient catchment area.

Birmingham itself has the youngest population of any UK city and is at the centre of a non-transient regional population of over five million. A potential cohort of patients which is both large and well-phenotyped.

Healthcare Informatics 

West Midlands Virtual Hospital
A 3D procurement tool designed to showcase the West Midlands supply chain to professionals in the healthcare sector
More Centres of Excellence:

  • Two Centres for Rare Diseases
  • Wellcome Trust Clinical Research Facility
  • National Institute for Health Research (NIHR) Centre for Surgical Reconstruction and
  • Microbiology Research Centre

University of Birmingham

  • Facility for Environmental Nanoscience Analysis & Characterisation
  • Nanoscale Physics Research Laboratory
  • Henry Wellcome Building for Biomolecular Nuclear Magnetic Resonance Spectroscopy
  • Cancer Research UK Clinical Trials Unit at University of Birmingham
  • Biorepository Centre (HBRC)
  • Birmingham Clinical Trials Unit
  • Clinical Immunology Service
  • Phenome Centre
  • NIHR Liver Biomedical Research Centre

Aston University

  • Centre for Vision and Hearing Research, including CAVE imaging room

Queen Elizabeth Hospital Birmingham

  • Centre for Clinical Haematology

National Centre for Mental Health

Life Sciences brochure

Life Sciences 

 

Your basket

0 items

Contact us

Invest team
+44 (0)121 202 5022

Media team
+44 (0)121 202 5112

Make an enquiry 

Contact

Contact Us